Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model

Metformin treatment conferred protection against early AF stabilization and selectively attenuated right atrial substrate complexity in a translationally relevant preclinical model. These findings support metformin as a lead molecule for AF prevention, warranting further mechanistic and clinical studies.

Authors

Institutions

Publication Details

Journal
Circulation Arrhythmia and Electrophysiology
Published
2025-12-01
DOI
https://doi.org/10.1161/circep.125.013850
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model

Vladimír Sobota, Joakim Bastrup, Colin C. Schwarzwald, Rasmus Kjøbsted et al.
Circulation Arrhythmia and Electrophysiology
Diabetes Treatment and Management
article

Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model

Vladimír Sobota, Joakim Bastrup, Colin C. Schwarzwald, Rasmus Kjøbsted, Rikke Buhl, Romain Barrès, Charlotte Hopster‐Iversen, Stefan M. Sattler, Sarah Dalgas Nissen, Kate M. Herum, Thomas Jespersen, Jørgen F. P. Wojtaszewski, Arnela Saljic, Urmas Roostalu, Steen Larsen, Arne van Hunnik, Simon Libak Haugaard, Stanley Nattel, Sofie Troest Kjeldsen, Helena Carstensen, Ali Altıntaş, Jesper B. Birk, Thomas A. Jepps, Christian M. Hansen, Mélodie J. Schneider, Sheyla Barrado Ballestero, Josefine Natalie Synnestvedt
article en

Abstract

Metformin treatment conferred protection against early AF stabilization and selectively attenuated right atrial substrate complexity in a translationally relevant preclinical model. These findings support metformin as a lead molecule for AF prevention, warranting further mechanistic and clinical studies.

Circulation Arrhythmia and ElectrophysiologyVol. 18(12)
University of Copenhagen (DK), Centre National de la Recherche Scientifique (FR), Medical University of Białystok (PL), Université de Bordeaux (FR), Novo Nordisk (Denmark) (DK), Montreal Heart Institute (CA), Novo Nordisk Foundation (DK), Frederiksberg Hospital (DK), Maastricht University (NL), Electrophysiology and Heart Modeling Institute (FR), Swiss Institute of Equine Medicine (CH), Center for Pediatric Endocrinology Zurich (CH), Bristol-Myers Squibb (India) (IN), Institut de Pharmacologie Moléculaire et Cellulaire (FR), West German Heart and Vascular Center Essen (DE), Institut de Mathématiques de Bordeaux (FR)
Openalex Percentile: Top 50%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.